Bulletin BiblioDemhttps://oskar-bordeaux.fr/handle/20.500.12278/1722492024-03-29T05:55:44Z2024-03-29T05:55:44ZBulletin BiblioDem 2024-21-1COMITÉ DE RÉDACTION BIBLIODEM, /https://oskar-bordeaux.fr/handle/20.500.12278/1887962024-03-15T01:02:52Z2024-03-14T00:00:00ZBulletin BiblioDem 2024-21-1
COMITÉ DE RÉDACTION BIBLIODEM, /
Dans ce numéro les articles suivants ont été analysés. 1. Amano T, Halvorsen CJ, Kim S, Reynolds A, Scher C, Jia Y. An outcome-wide analysis of the effects of diagnostic labeling of Alzheimer's disease and related dementias on social relationships. Alzheimers Dement. 2023. 2. Lachner C, Craver EC, Babulal GM, Lucas JA, Ferman TJ, White RO, et al. Disparate Dementia Risk Factors Are Associated with Cognitive Impairment and Rates of Decline in African Americans. Ann Neurol. 2024;95(3):518-29. 3. Roncarati JS, DeVone F, Halladay C, Tsai J, Jutkowitz E. Risk of dementia among veterans experiencing homelessness and housing instability. J Am Geriatr Soc. 2024;72(2):382-9. 4. Shulman M, Kong J, O'Gorman J, Ratti E, Rajagovindan R, Viollet L, et al. TANGO: a placebo-controlled randomized phase 2 study of efficacy and safety of the anti-tau monoclonal antibody gosuranemab in early Alzheimer's disease. Nat Aging. 2023;3(12):1591-601. 5. Yaffe K, Vittinghoff E, Dublin S, Peltz CB, Fleckenstein LE, Rosenberg DE, et al. Effect of Personalized Risk-Reduction Strategies on Cognition and Dementia Risk Profile Among Older Adults: The SMARRT Randomized Clinical Trial. JAMA Intern Med. 2024;184(1):54-62.
2024-03-14T00:00:00ZBulletin BiblioDem 2023-20-11/12COMITÉ DE RÉDACTION BIBLIODEM, /https://oskar-bordeaux.fr/handle/20.500.12278/1885912024-03-07T08:46:18Z2024-02-23T00:00:00ZBulletin BiblioDem 2023-20-11/12
COMITÉ DE RÉDACTION BIBLIODEM, /
Dans ce numéro, les articles suivants ont été analysés. 1. Aiken-Morgan AT, Capuano AW, Wilson RS, Barnes LL. Changes in Body Mass Index and Incident Mild Cognitive Impairment Among African American Older Adults. J Gerontol A Biol Sci Med Sci. 2023;79(3). 2. Edwards AL, Collins JA, Junge C, Kordasiewicz H, Mignon L, Wu S, et al. Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer Disease: A Randomized Clinical Trial. JAMA Neurol. 2023;80(12):1344-52. 3. Himali JJ, Baril AA, Cavuoto MG, Yiallourou S, Wiedner CD, Himali D, et al. Association Between Slow-Wave Sleep Loss and Incident Dementia. JAMA Neurol. 2023;80(12):1326-33. 4. Lee D, Slomkowski M, Hefting N, Chen D, Larsen KG, Kohegyi E, et al. Brexpiprazole for the Treatment of Agitation in Alzheimer Dementia: A Randomized Clinical Trial. JAMA Neurol. 2023;80(12):1307-16. 5. Pyer M, Ward A. Developing a dementia friendly approach to consent in dementia research. Aging Ment Health. 2024;28(2):294-301. 6. Reboucas SCL, Cougnard-Gregoire A, Arnould L, Delyfer MN, Schweitzer C, Korobelnik JF, et al. Retinal microvasculature and incident dementia over 10 years: The Three-City-Alienor cohort. Alzheimers Dement (Amst). 2023;15(4):e12480. 7. Saltiel N, Tripodis Y, Menzin T, Olaniyan A, Baucom Z, Yhang E, et al. Relative Contributions of Mixed Pathologies to Cognitive and Functional Symptoms in Brain Donors Exposed to Repetitive Head Impacts. Ann Neurol. 2024;95(2):314-24. 8. Yu DSF, Cheng ST, Chow EO, Kwok T, McCormack B, Wu W. The effects of a salutogenic strength-based intervention on sense of coherence and health outcomes of dementia family carers: A randomized controlled trial. Age Ageing. 2023;52(9).
2024-02-23T00:00:00ZBulletin BiblioDem 2023-20-10COMITÉ DE RÉDACTION BIBLIODEM, /https://oskar-bordeaux.fr/handle/20.500.12278/1863432023-12-06T01:05:22Z2023-12-04T00:00:00ZBulletin BiblioDem 2023-20-10
COMITÉ DE RÉDACTION BIBLIODEM, /
Dans ce numéro, les articles suivants ont été analysés : 1. Ferrante FJ, Migeot J, Birba A, Amoruso L, Perez G, Hesse E, et al. Multivariate word properties in fluency tasks reveal markers of Alzheimer's dementia. Alzheimers Dement. 2023.
2. Chanti-Ketterl M, Pieper CF, Yaffe K, Plassman BL. Associations Between Traumatic Brain Injury and Cognitive Decline Among Older Male Veterans: A Twin Study. Neurology. 2023;101(18):e1761-e70.
3. de Crom TOE, Steur M, Ikram MK, Ikram MA, Voortman T. Plant-based dietary patterns and the risk of dementia: a population-based study. Age Ageing. 2023;52(9).
4. Devanand DP, Goldberg TE, Qian M, Rushia SN, Sneed JR, Andrews HF, et al. Computerized Games versus Crosswords Training in Mild Cognitive Impairment. NEJM Evid. 2022;1(12).
5. Qureshi D, Collister J, Allen NE, Kuzma E, Littlejohns T. Association between metabolic syndrome and risk of incident dementia in UK Biobank. Alzheimers Dement. 2023.
6. Sala G, Nishita Y, Tange C, Shu Z, Ando F, Shimokata H, et al. Differential longitudinal associations between domains of cognitive function and physical function: A 20-year follow-up study. J Gerontol B Psychol Sci Soc Sci. 2023.
7. Qureshi D, Collister J, Allen NE, Kuzma E, Littlejohns T. Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease. JAMA Neurol. 2023.
8. Zulke AE, Pabst A, Luppa M, Roehr S, Seidling H, Oey A, et al. A multidomain intervention against cognitive decline in an at-risk-population in Germany: Results from the cluster-randomized AgeWell.de trial. Alzheimers Dement. 2023.
2023-12-04T00:00:00ZBulletin BiblioDem 2023-20-8/9COMITÉ DE RÉDACTION BIBLIODEM, /https://oskar-bordeaux.fr/handle/20.500.12278/1861582023-11-29T01:05:07Z2023-11-27T00:00:00ZBulletin BiblioDem 2023-20-8/9
COMITÉ DE RÉDACTION BIBLIODEM, /
1. Grasset L, Planche V, Bouteloup V, Azouani C, Dubois B, Blanc F, et al. Physical activity, biomarkers of brain pathologies and dementia risk: Results from the Memento clinical cohort. Alzheimers Dement. 2023. 2. Hirabayashi N, Honda T, Hata J, Furuta Y, Shibata M, Ohara T, et al. Association Between Frequency of Social Contact and Brain Atrophy in Community-Dwelling Older People Without Dementia: The JPSC-AD Study. Neurology. 2023;101(11):e1108-e17. 3. Johansen MC, Ye W, Gross A, Gottesman RF, Han D, Whitney R, et al. Association Between Acute Myocardial Infarction and Cognition. JAMA Neurol. 2023;80(7):723-31. 4. Jonsson L, Wimo A, Handels R, Johansson G, Boada M, Engelborghs S, et al. The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint. Lancet Reg Health Eur. 2023;29:100657. 5. Nelson PT, Schneider JA, Jicha GA, Duong MT, Wolk DA. When Alzheimer's is LATE: Why Does it Matter? Ann Neurol. 2023;94(2):211-22. 6. Oostra DL, Nieuwboer MS, Melis RJF, Remers TEP, Olde Rikkert MGM, Perry M. DementiaNet facilitates a sustainable transition toward integrated primary dementia care: A long-term evaluation. Alzheimers Dement. 2023. 7. Sperling RA, Donohue MC, Raman R, Rafii MS, Johnson K, Masters CL, et al. Trial of Solanezumab in Preclinical Alzheimer's Disease. N Engl J Med. 2023;389(12):1096-107. 8. Wiese LAK, Gibson A, Guest MA, Nelson AR, Weaver R, Gupta A, et al. Global rural health disparities in Alzheimer's disease and related dementias: State of the science. Alzheimers Dement. 2023;19(9):4204-25.
2023-11-27T00:00:00ZBulletin BiblioDem 2023 20-6/7COMITÉ DE RÉDACTION BIBLIODEM, /https://oskar-bordeaux.fr/handle/20.500.12278/1845132023-11-21T15:30:49Z2023-10-24T00:00:00ZBulletin BiblioDem 2023 20-6/7
COMITÉ DE RÉDACTION BIBLIODEM, /
Articles analysés dans ce numéro : 1. Coleman ME, Roessler MEH, Peng S, Roth AR, Risacher SL, Saykin AJ, et al. Social enrichment on the job: Complex work with people improves episodic memory, promotes brain reserve, and reduces the risk of dementia. Alzheimers Dement. 2023;19(6):2655-65. 2.Evans CD, Sparks J, Andersen SW, Brooks DA, Hauck PM, Mintun MA, et al. APOE epsilon4's impact on response to amyloid therapies in early symptomatic Alzheimer's disease: Analyses from multiple clinical trials. Alzheimers Dement. 2023. 3. Garnier-Crussard A, Cotton F, Krolak-Salmon P, Chetelat G. White matter hyperintensities in Alzheimer's disease: Beyond vascular contribution. Alzheimers Dement. 2023;19(8):3738-48. 4. Moran C, Lacy ME, Whitmer RA, Tsai AL, Quesenberry CP, Karter AJ, et al. Glycemic Control Over Multiple Decades and Dementia Risk in People With Type 2 Diabetes. JAMA Neurol. 2023;80(6):597-604. 5. Sachs BC, Williams BJ, Gaussoin SA, Baker LD, Manson JE, Espeland MA, et al. Impact of multivitamin-mineral and cocoa extract on incidence of mild cognitive impairment and dementia: Results from the COcoa Supplement and Multivitamin Outcomes Study for the Mind (COSMOS-Mind). Alzheimers Dement. 2023. 6. Wilker EH, Osman M, Weisskopf MG. Ambient air pollution and clinical dementia: systematic review and meta-analysis. BMJ. 2023;381:e071620. 7. Windle G, Roberts J, MacLeod C, Algar-Skaife K, Sullivan MP, Brotherhood E, et al. 'I have never bounced back': resilience and living with dementia. Aging Ment Health. 2023;27(12):2355-67. 8. Wong ATY, Reeves GK, Floud S. Total sleep duration and daytime napping in relation to dementia detection risk: Results from the Million Women Study. Alzheimers Dement. 2023.
9. Zhong W, Chen H, Gong X, Tong L, Xu X, Zong G, et al. Prevalent stroke, age of its onset, and post-stroke lifestyle in relation to dementia: A prospective cohort study. Alzheimers Dement. 2023;19(9):3998-4007.
2023-10-24T00:00:00ZBulletin BiblioDem 2023-20-05COMITÉ DE RÉDACTION BIBLIODEM, /https://oskar-bordeaux.fr/handle/20.500.12278/1834592023-11-16T15:03:23Z2023-07-20T00:00:00ZBulletin BiblioDem 2023-20-05
COMITÉ DE RÉDACTION BIBLIODEM, /
Articles analysés dans ce numéro 1. Cheng Y, Zamrini E, Faselis C, Redd D, Shao Y, Morgan CJ, et al. Cardiorespiratory fitness and risk of Alzheimer's disease and related dementias among American veterans. Alzheimers Dement. 2023.
2. Lavallée PC, Charles H, Albers GW, Caplan LR, Donnan GA, Ferro JM, et al. Effect of atherosclerosis on 5-year risk of major vascular events in patients with transient ischaemic attack or minor ischaemic stroke: an international prospective cohort study. Lancet Neurol. 2023;22(4):320-9.
3. Liu C, Ma Y, Hofman A, Waziry R, Koton S, Pike JR, et al. Educational Attainment and Dementia: Mediation by Mid-Life Vascular Risk Factors. Ann Neurol. 2023.
4. Lucey BP, Liu H, Toedebusch CD, Freund D, Redrick T, Chahin SL, et al. Suvorexant acutely decreases tau phosphorylation and Aβ in the human CNS. Ann Neurol. 2023.
5. McMaster M, Kim S, Clare L, Torres SJ, Cherbuin N, Anstey KJ. The feasibility of a multidomain dementia risk reduction randomised controlled trial for people experiencing cognitive decline: the Body, Brain, Life for Cognitive Decline (BBL-CD). Aging Ment Health. 2023:1-9.
6. Ueda P, Pasternak B, Lim CE, Neovius M, Kader M, Forssblad M, et al. Neurodegenerative disease among male elite football (soccer) players in Sweden: a cohort study. Lancet Public Health. 2023.
7. Van Orden KA, Bower E, Lutz J, Silva C. Engage coaching for caregivers: a pilot trial to reduce loneliness in dementia caregivers. Aging Ment Health. 2023:1-8.
2023-07-20T00:00:00ZBulletin BiblioDem 2023-20-04 COMITÉ DE RÉDACTION BIBLIODEM, /https://oskar-bordeaux.fr/handle/20.500.12278/1823442023-11-21T15:24:35Z2023-05-25T00:00:00ZBulletin BiblioDem 2023-20-04
COMITÉ DE RÉDACTION BIBLIODEM, /
1. Charisis S, Lin H, Ray R, Joehanes R, Beiser AS, Levy D, et al. Obesity impacts the expression of Alzheimer's disease-related genes: The Framingham Heart Study. Alzheimers Dement. 2023.
2. Dubois B, Lopez-Arrieta J, Lipschitz S, Doskas T, Spiru L, Moroz S, et al. Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial. Alzheimers Res Ther. 2023;15(1):39.
3. Gao L, Li P, Gaykova N, Zheng X, Gao C, Lane JM, et al. Circadian Rest-Activity Rhythms, Delirium Risk, and Progression to Dementia. Ann Neurol. 2023.
4. Grodstein F, Leurgans SE, Capuano AW, Schneider JA, Bennett DA. Trends in Postmortem Neurodegenerative and Cerebrovascular Neuropathologies Over 25 Years. JAMA Neurol. 2023;80(4):370-6.
5. Guo J, Song S. Associations of height loss with cognitive decline and incident dementia in adults aged 50 years and older. J Gerontol A Biol Sci Med Sci. 2023.
6. Karamacoska D, Tan T, Mathersul DC, Sabag A, de Manincor M, Chang D, et al. A systematic review of the health effects of yoga for people with mild cognitive impairment and dementia. BMC Geriatr. 2023;23(1):37.
7. Li N, Deng Q, Yang Q, Wang Y, Hu J, Zhao X, et al. Effect of physical activity intervention on cognitive function in China: A cluster randomized trial. Alzheimers Dement. 2023.
8. Petersen RC, Aisen PS, Andrews JS, Atri A, Matthews BR, Rentz DM, et al. Expectations and clinical meaningfulness of randomized controlled trials. Alzheimers Dement. 2023.
9. Yu X, Westrick AC, Kobayashi LC. Cumulative loneliness and subsequent memory function and rate of decline among adults aged >/=50 in the United States, 1996 to 2016. Alzheimers Dement. 2023;19(2):578-88.
2023-05-25T00:00:00ZBulletin BiblioDem 2023-20-03COMITÉ DE RÉDACTION BIBLIODEMhttps://oskar-bordeaux.fr/handle/20.500.12278/1729742023-11-21T15:19:09Z2023-03-20T00:00:00ZBulletin BiblioDem 2023-20-03
COMITÉ DE RÉDACTION BIBLIODEM
Articles analysés dans ce numéro : 1. Bancks MP, Byrd GS, Caban-Holt A, Fitzpatrick AL, Forrester SN, Hayden KM, et al. Self-reported experiences of discrimination and incident dementia. Alzheimers Dement. 2023.
2. Dubbelman MA, Sikkes SAM, Ebenau JL, van Leeuwenstijn M, Kroeze LA, Trieu C, et al. Changes in self- and study partner-perceived cognitive functioning in relation to amyloid status and future clinical progression: Findings from the SCIENCe project. Alzheimers Dement. 2023.
3. Florian H, Wang D, Arnold SE, Boada M, Guo Q, Jin Z, et al. Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study. Brain. 2023.
4. Grasset L, Power MC, Crivello F, Tzourio C, Chene G, Dufouil C. How Traumatic Brain Injury History Relates to Brain Health MRI Markers and Dementia Risk: Findings from the 3C Dijon Cohort. J Alzheimers Dis. 2023;92(1):183-93.
5. Huang AR, Roth DL, Cidav T, Chung SE, Amjad H, Thorpe RJ, Jr., et al. Social isolation and 9-year dementia risk in community-dwelling Medicare beneficiaries in the United States. J Am Geriatr Soc. 2023;71(3):765-73.
6. Jia J, Zhao T, Liu Z, Liang Y, Li F, Li Y, et al. Association between healthy lifestyle and memory decline in older adults: 10 year, population based, prospective cohort study. BMJ. 2023;380:e072691.
7. Salvado G, Larsson V, Cody KA, Cullen NC, Jonaitis EM, Stomrud E, et al. Optimal combinations of CSF biomarkers for predicting cognitive decline and clinical conversion in cognitively unimpaired participants and mild cognitive impairment patients: A multi-cohort study. Alzheimers Dement. 2023.
2023-03-20T00:00:00ZBulletin BiblioDem 2023-20-02COMITE DE REDACTION BIBLIODEMhttps://oskar-bordeaux.fr/handle/20.500.12278/1722872023-11-21T15:18:08Z2023-02-01T00:00:00ZBulletin BiblioDem 2023-20-02
COMITE DE REDACTION BIBLIODEM
Articles analysés dans ce numéro
1. Anantapong K, Davies N, Sampson EL. Communication between the multidisciplinary team and families regarding nutrition and hydration for people with severe dementia in acute hospitals: a qualitative study. Age Ageing. 2022;51(11).
2. Boerwinkle AH, Gordon BA, Wisch J, Flores S, Henson RL, Butt OH, et al. Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study. Lancet Neurol. 2023;22(1):55-65.
3. Burgdorf JG, Amjad H. Impact of diagnosed (vs undiagnosed) dementia on family caregiving experiences. J Am Geriatr Soc. 2022.
4. de Crom TOE, Ginos BNR, Oudin A, Ikram MK, Voortman T, Ikram MA. Air Pollution and the Risk of Dementia: The Rotterdam Study. J Alzheimers Dis. 2023;91(2):603-13.
5. Felstead C, Perkins L, Stott J, Hui EK, Spector A. A systematic literature review of group-based training interventions for informal carers: impact on the behavioural and psychological symptoms of dementia (BPSD). Aging Ment Health. 2022:1-10.
6. Gotanda H, Tsugawa Y, Xu H, Reuben DB. Life satisfaction among persons living with dementia and those without dementia. J Am Geriatr Soc. 2022.
7. Huang AR, Rebok GW, Swenor BK, Reed N, Griswold M, Zhu X, et al. Concurrent hearing and vision impairment and 8-year memory decline in community-dwelling older adults. Alzheimers Dement. 2022.
8. Kleineidam L, Wagner M, Guski J, Wolfsgruber S, Miebach L, Bickel H, et al. Disentangling the relationship of subjective cognitive decline and depressive symptoms in the development of cognitive decline and dementia. Alzheimers Dement. 2022.
9. Li J, Liu C, Ang TFA, Au R. BMI decline patterns and relation to dementia risk across four decades of follow-up in the Framingham Study. Alzheimers Dement. 2022.
10. Sutin AR, Luchetti M, Aschwanden D, Zhu X, Stephan Y, Terracciano A. Loneliness and risk of all-cause, Alzheimer's, vascular, and frontotemporal dementia: a prospective study of 492,322 individuals over 15 years. Int Psychogeriatr. 2022:1-10.
11. Therriault J, Vermeiren M, Servaes S, Tissot C, Ashton NJ, Benedet AL, et al. Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography. JAMA Neurol. 2023;80(2):188-99.
12. van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in Early Alzheimer's Disease. N Engl J Med. 2023;388(1):9-21.
2023-02-01T00:00:00ZBulletin BiblioDem 2023-20-01COMITE DE REDACTION BIBLIODEMhttps://oskar-bordeaux.fr/handle/20.500.12278/1722842023-11-21T15:16:55Z2023-02-01T00:00:00ZBulletin BiblioDem 2023-20-01
COMITE DE REDACTION BIBLIODEM
2023-02-01T00:00:00Z